The depletion of CD4+ T cells one day before vaccination with SA-4-1BBL admixed with survivin (SVN) as self TAA had no detectable effect on the therapeutic efficacy of the vaccine in the 3LL lung carcinoma model expressing SVN (Fig. 4C). This evidence concerns the gene BIRC5 and lung carcinoma.